TGA AustraliaOverený účet

@TGAgovau

Australia's medicines and medical devices regulator See our website for our social media acceptable use policy.

Na Twitteri od: október 2015

Tweety

Zablokovali ste používateľa @TGAgovau

Naozaj chcete zobraziť tieto Tweety? Zobrazenie Tweetov neodblokuje používateľa @TGAgovau

  1. pred 6 hodinami

    We have provisionally approved the use of the Roche Products Pty Ltd combination therapy, casirivimab + imdevimab (RONAPREVE), for the treatment and prevention of in specific target populations. Read more on our website:

    Späť
  2. pred 6 hodinami

    ‼️ TOMORROW ‼️ Join us online for part two of the role of a Unique Device Identification (UDI) Issuing Agency at 11:30am. Register now 👉

    Späť
  3. 15. 10.

    TGA decision: Brukinsa (zanubrutinib) is indicated for the treatment of adult patients with mantle cell lymphoma (MCL). Read more:

    Späť
  4. 14. 10.

    📢 Join us and the panel on Wednesday 20 October at 7pm (Australian Eastern Daylight Saving Time) to discuss nicotine vaping products, the UK smoking cessation experience and practical tips for Australian prescribers. Register online 👉

    Späť
  5. 14. 10.

    Vaccination against COVID-19 is the single most effective way to reduce severe illness and death from infection. Get reliable and up-to-date information about the safety of the vaccines in our vaccine weekly safety report. Read more:

    Späť
  6. 14. 10.

    🖥️ Have you registered for our fifth on the Australian Unique Device Identification (UDI) system? Join us online at 11:30am on Tuesday 19 October from for part two of the role of a UDI Issuing Agency. 👉

    Späť
  7. 13. 10.

    We have granted a provisional determination to Pfizer Australia in relation to its vaccine, COMIRNATY. Pfizer is now eligible to apply to the TGA to vary the provisional approval for the vaccine to include children aged 5 to 11 years. Read more:

    Späť
  8. 13. 10.

    📢 Join us and the panel on Thursday 14 October at 6pm (Australian Eastern Daylight Saving Time) to discuss nicotine vaping products, the NZ smoking cessation experience and practical tips for Australian prescribers. Register online 👉

    Späť
  9. 13. 10.

    If the names of inactive ingredients are not listed on the medicine label, you can find this information by searching for the medicine on the TGA website. Find out more:

    Späť
  10. 12. 10.

    📢 Part five of our series on the Australian Unique Device Identification (UDI) system is on Tuesday 19 October from 11:30am-12:30pm. Register online 👉

    Späť
  11. 11. 10.

    Health professionals are advised that the Product Information (PI) for pentosan polysulfate sodium has been updated with a warning about potential pigmentary maculopathy, especially after long-term use. See our latest MSU for more information:

    Späť
  12. 11. 10.

    New AusPAR for Phesgo SC (pertuzumab/trastuzumab) for the treatment of early breast cancer and metastatic breast cancer. Read more:

    Späť
  13. 10. 10.

    Do you advertise medicines or medical devices on social media? Read our social media advertising guide to ensure that you’re complying with the rules:

    Späť
  14. 8. 10.

    When the TGA has made a decision that relevant sponsors are eligible to apply for provisional registration for COVID-19 treatments in the ARTG. See the list of treatments with provisional determination 👉

    Späť
  15. 8. 10.

    Cuprior (trientine tetrahydrochloride) is approved to treat Wilson’s disease. Read more:

    Späť
  16. 7. 10.

    New AusPAR for Zebinix (eslicarbazepine acetate) for the treatment of partial onset seizures. Read more:

    Späť
  17. 7. 10.

    Vaccination against COVID-19 is the single most effective way to reduce severe illness and death from infection. Get reliable and up-to-date information about the safety of the vaccines in our vaccine weekly safety report. Read more:

    Späť
  18. 7. 10.

    Navigating how to supply medicinal cannabis in Australia can be a challenge. Come along to TGA’s SME Assist workshop on Supplying Medicinal Cannabis in Australia on Thursday 21 October. Register now:

    Späť
  19. 6. 10.

    We have granted provisional determination to Pfizer Australia in relation to a new combination medicine containing PF-07321332 and ritonavir, for the treatment of adult patients with symptomatic, confirmed infection. Read more:

    Späť
  20. 6. 10.

    Even if you're familiar with your pet's medicine, the advice is clear: if a product is labelled 'for animal use only', do not take it. Find out more about the dangers of taking your pets’ medicine:

    Späť

Načítavanie bude chvíľu trvať.

Twitter je preťažený alebo sa vyskytla neočakávaná chyba. Skúste to znova alebo navštívte stránku Twitter Status, ktorá obsahuje viac informácií.

    Môže sa vám páčiť aj

    ·